About the role

Uses an understanding of disease biology, the drug development process (particularly cross-functional connectivity), and relevant late-stage challenges to create a vision for each asset, then design and execute effective development programs in support of the overall R&D portfolio goals.
Effectively engages cross company expertise and utilizes advisory groups and governance bodies to define, revise and champion asset development strategies and implementation plans.
Continually analyzes progress, engages in critical thinking, and asserts strong problem-solving toward delivering key data and interpretation essential for robust debate and rapid, data-driven decision making on assigned projects.
Delivers high quality assets to commercial which have the potential for a competitive profile to address the unmet medical needs of patients and to provide favorable shareholder return.
Ensures the process and output of the team meets established program standards, while also looking for opportunities to streamline development and enable continuous improvements without compromising quality.
Engages senior leaders and functional area stakeholders to ensure alignment of program strategy and operational plans with functional area capabilities.
Actively provides input to and drives portfolio level strategy for both internal and external opportunities.
Participates in regulatory filings (NDA, BLA filings) as well as develops strategy for orphan drug designation.
Engages with Health Authorities and/or Advisory Committees in the design of clinical trials and endpoints.
Leads team to develop program strategy and clinical program, commercialization strategy plans, business case development, and understands how access, pricing and reimbursement needs for supporting value proposition will inform trial design.
Builds and maintains collaborative relationships with external stakeholders and appropriately incorporates insights and advice to maximize program impact.

Requirements

MD, PhD, DVM, PharmD, MBA or equivalent advanced degree of relevance, with experience in the drug development process.
10+ years of experience in the drug development process and leadership experience in academic or industry setting, including education where applicable.
Expertise in the drug development process with in-depth know how and experience in matrix team leadership, relevant regulatory expectations, and overall drug development and commercialization.
Successful track record of leading through influence and working across complex, global organizational matrix.
Significant experience in immunology preferred, with demonstrated understanding of the role of basic biology, pharmaceutical optimization, translational medicine, and clinical pharmacology, including exposure-response relationships and dose selection.
Strong understanding of relevant regulatory health authority expectations and regulations for drug development and impact on commercialization.
Working knowledge of all functional areas of exploratory development, including chemistry/biochemistry, biology, toxicology, CMC, translational medicine, early clinical development, etc.
Demonstrated scientific acumen and mechanistic understanding of pharmacology and disease biology.
Ability to create a clear purpose, global vision, strategies and key priorities for competing successfully in the evolving pharmaceutical and health care industry.
Demonstrated ability to lead cross-functional team to execute Development Plans which have global perspective and focus on product differentiation, including opportunities for data driven acceleration.
Demonstrated ability to objectively assess complex but relatively sparse data sets, make informed decisions and take action in the face of uncertainty.
Demonstrated ability to present complex programs to senior leaders and influence decision making.
Experience in successfully managing and leading high performing, cross-functional matrix teams or complex multi-functional organizations.
Demonstrated ability to coach and mentor others to enhance performance and/or facilitate career progression.
Ability to effectively and seamlessly multi-task, and prioritize across multiple development assets, with complex strategies and accelerated development timelines.
Demonstrated ability to successfully and effectively cooperate, collaborate and work across functions.
Demonstrated ability to advise and participate in business development due-diligence evaluations and transaction recommendations.

Benefits

Medical, pharmacy, dental and vision care.
Wellbeing support such as the BMS Living Life Better program and employee assistance programs (EAP).
Financial well-being resources and a 401(K).
Financial protection benefits such as short- and long-term disability, life insurance, supplemental health insurance, business travel protection and survivor support.
Work-life programs include paid national holidays and optional holidays, Global Shutdown Days between Christmas and New Year’s holiday, up to 120 hours of paid vacation, up to two (2) paid days to volunteer, sick time off, and summer hours flexibility.
Parental, caregiver, bereavement, and military leave.
Family care services such as adoption and surrogacy reimbursement, fertility/infertility benefits, support for traveling mothers, and child, elder and pet care resources.
Other perks like tuition reimbursement and a recognition program.

Hybrid Executive Director, Global Development Lead – Next Generation, Immunology, Cardiovascular

About the role

Requirements

Benefits

Job title

Job type

Experience level

Salary

Degree requirement

Location requirements

Report this job

Similar roles